Key result
The AIMS65 score was associated with in-hospital mortality risk in patients with upper gastrointestinal bleeding, demonstrating superiority over the Glasgow-Blatchford and Rockall scores.
Why the study?
The study aimed to evaluate and compare the performance of the AIMS65 score, Glasgow-Blatchford score, and Rockall score for predicting clinical outcomes in patients with nonvariceal versus variceal upper gastrointestinal bleeding.
Does the AIMS65 score better predict clinical outcomes compared to the Glasgow-Blatchford score and Rockall score in patients with upper gastrointestinal bleeding?
Observational (n=337)
No
Does the AIMS65 score better predict clinical outcomes compared to the Glasgow-Blatchford score and Rockall score in patients with upper gastrointestinal bleeding?
The AIMS65 score is superior to the Glasgow-Blatchford and Rockall scores in predicting in-hospital mortality among patients with upper gastrointestinal bleeding.
Answers are grounded in this paper and cite their sources.
AIMS65 may aid mortality risk stratification in upper GI bleeding; hypothesis-generating and should not yet change practice.
BACKGROUND/AIMS: This study aimed to determine the performance of the AIMS65 score (AIMS65), Glasgow-Blatchford score (GBS), and Rockall score (RS) in predicting outcomes in patients with upper gastrointestinal bleeding (UGIB), and to compare the results between patients with nonvariceal UGIB (NVUGIB) and those with variceal UGIB (VUGIB). METHODS: We conducted a prospective observational study between March 2016 and December 2017. Receiver operating characteristic curve analysis was performed for all outcomes for comparison. The associations of all three scores with mortality were evaluated using multivariate logistic regression analysis. RESULTS: Of the total of 337 patients with UGIB, 267 patients (79.2%) had NVUGIB. AIMS65 was significantly associated (odds ratio [OR], 1.735; 95% confidence interval [CI], 1.148-2.620), RS was marginally associated (OR, 1.225; 95% CI, 0.973-1.543), but GBS was not associated (OR, 1.017; 95% CI, 0.890-1.163) with mortality risk in patients with UGIB. However, all three scores accurately predicted all other outcomes (all p<0.05) except rebleeding (p>0.05). Only AIMS65 precisely predicted mortality, the need for blood transfusion and the composite endpoint (all p<0.05) in patients with VUGIB. CONCLUSION: AIMS65 is superior to GBS and RS in predicting mortality in patients with UGIB, and also precisely predicts the need for blood transfusion and the composite endpoint in patients with VUGIB. No scoring system could satisfactorily predict rebleeding in all patients with UGIB.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2020) conducted an observational in Upper gastrointestinal bleeding (n=337). AIMS65 score vs. Glasgow-Blatchford score and Rockall score was evaluated on In-hospital mortality (OR 1.735, 95% CI 1.148-2.620, p=0.009). The AIMS65 score was associated with in-hospital mortality risk in patients with upper gastrointestinal bleeding, demonstrating superiority over the Glasgow-Blatchford and Rockall scores.
Synapse has enriched 10 related papers. Consider them for comparative context: